Blog
RSS FeedPosted by Michael Wonder on 21 May 2016
Bill Shorten's $1b promise to keep medicine costs down
22 May 2016 - Labor is promising to keep the cost of prescription medicines down by officially ditching the Coalition's "medicine ...
Posted by Michael Wonder on 19 May 2016
Sydney mother calls for cystic fibrosis drug Orkambi to be accessible for daughter
20 May 2016 - West Pymble six-year-olds Charli and Jasmine are twins, but their future lives look very different. ...
Posted by Michael Wonder on 13 May 2016
Drug that saved Ron Walker could help wide range of cancer patients
13 May 2016 - A drug that saved Ron Walker from melanoma may also be able to save patients from 30 ...
Posted by Michael Wonder on 12 May 2016
Unfair if rare: should the PBS change the way it lists cancer drugs?
12 May 2016 - The PBS spends over A$9 billion a year subsidising a wide range of drugs to ensure affordability ...
Posted by Michael Wonder on 11 May 2016
Statement from the Panel for the Review of Pharmacy Remuneration and Regulation
12 May 2016 - On 9 May 2016, the Australian Government went into ‘caretaker’ mode. After consultation by the Secretariat with the ...
Posted by Michael Wonder on 09 May 2016
Changes needed to selection of PBS cancer medicines: experts
9 May 2016 - A leading cancer expert says there needs to be a change to the way cancer drugs are ...
Posted by Michael Wonder on 09 May 2016
Cancer patient pays $5,000 every two weeks for treatment costing others just $6.20
9 May 2016 - At the age of 36, Danielle Tindle has been given an ultimatum — your money or your ...
Posted by Michael Wonder on 09 May 2016
Updated treatment algorithm for the treatment of HER2+ metastatic breast cancer
1 May 2016 - The PBAC treatment algorithm for anti-HER2 therapies for treating metastatic breast cancer has been updated to reflect ...
Posted by Michael Wonder on 07 May 2016
Pharmaceutical Benefits Advisory Committee Guidelines review
6 May 2016 - The public consultation processes on the draft revised PBAC Guidelines (Version 5.0) and the assessment of co-dependent ...
Posted by Michael Wonder on 04 May 2016
PBS expenditure and prescriptions report 2014-15
4 May 2016 - The PBS expenditure and prescriptions report 2014-15 is now available. ...
Posted by Michael Wonder on 02 May 2016
Cystic fibrosis patients campaign for drug Orkambi to be listed on Pharmaceutical Benefits Scheme
2 May 2016 - Without subsidy, it costs about US $260,000 each year. ...
Posted by Michael Wonder on 02 May 2016
Are the days of big pharma dominating the agenda of a PBAC meeting over?
2 May 2016 - The sponsor with the most number of submissions on the agenda for the next PBAC meeting ...
Posted by Michael Wonder on 02 May 2016
Post-market reviews of pulmonary arterial hypertension medicines and biological DMARDs to treat severe chronic plaque psoriasis
2 May 2016 - The public consultation process is now open for two PBAC post-market reviews. ...
Posted by Michael Wonder on 01 May 2016
Schedule of Pharmaceutical Benefits - 1 May 2016 update
1 May 2016 - The May 2016 issue of the Schedule sees a number of new and revised listings. ...
Posted by Michael Wonder on 29 Apr 2016
PBS listing of tamoxifen citrate projected to benefit thousands of women
29 April 2016 - Thousands of women will benefit from subsidised access to the breast cancer drug Tamoxifen which has been ...